Biocide ERO MN authorized in the EU: what manufacturers and distributors must do

Key data

If your company manufactures, imports, distributes or professionally uses the biocide ERO MN, this regulation affects you directly from 8 September 2026. Commission Implementing Regulation (EU) 2026/1974 grants a Union authorization for this product, which means that it is no longer necessary to obtain individual national authorizations in each Member State: a single centralized authorization enables marketing throughout the EU under harmonized conditions.

This authorization is framed within the Regulation (EU) No 528/2012 on the marketing and use of biocidal products, the European regulatory framework that establishes the requirements for the approval of active substances and the authorization of biocidal products on the single market.

What does this regulation establish?

The regulation grants a single Union authorization for the biocide called ERO MN. This type of centralized authorization, managed by the European Commission, replaces the process of obtaining separate national authorizations in each EU country.

The key elements established by the regulation are:

• Centralized authorization: the product can be marketed in all EU Member States under the same conditions.
• Harmonized conditions of use: the regulation precisely sets out how the product must be used, with what restrictions and in what contexts.
• Labeling requirements: the product labeling must strictly comply with what is established in the authorization.
• Consequences of non-compliance: failure to comply with the conditions may result in administrative sanctions and product withdrawal from the market.

Union authorization is the most robust mechanism within the European biocides system: it provides legal certainty to the holder and facilitates commercial expansion in the single market, but it also requires rigorous and uniform compliance in all countries where the product is distributed.

Economic and operational impact

Obtaining centralized authorization has concrete operational and economic implications for companies in the sector:

• Reduction in authorization costs: by avoiding the need to obtain individual national authorizations in each Member State, the product holder can operate throughout the EU with a single regulatory file.
• Obligation of immediate adaptation: companies that were already marketing or using the product under national schemes must review whether their current conditions of use and labeling comply with the new terms of the Union authorization.
• Risk of market withdrawal: non-compliance with the conditions set out in the regulation may result in product withdrawal from the market, with the consequent impact on sales, contracts and business relationships.
• Administrative sanctions: the regulation expressly establishes that non-compliance may result in administrative sanctions, the specific amount of which will depend on the legislation of each Member State on biocides.

For professional users—industrial hygiene companies, pest control or chemical sectors that use this biocide in their processes—the entry into force of centralized authorization implies verifying that their internal procedures for use are consistent with the harmonized restrictions and conditions.

Who does it affect?

• Manufacturers of the biocide ERO MN that produce or formulate it in the EU.
• Distributors and wholesalers that market the product in one or more Member States.
• Importers that introduce the product into the European market from third countries.
• Professional users in the chemical, industrial hygiene or pest control sectors that use ERO MN in their operations.
• Compliance officers of companies operating with biocides in the EU.
• Regulatory advisors and product consultants that manage biocides documentation for their clients.

Practical example

A Spanish pest control company that uses the biocide ERO MN in its professional services must, as of 8 September 2026, verify that its application procedures, the safety data sheets it provides to its clients and the labeling of the product it purchases from its supplier comply with the conditions set out in Commission Implementing Regulation (EU) 2026/1974.

If the distributor supplier has not updated the product labeling in accordance with the new Union authorization, both the distributor and the professional user could be in breach of the regulation, with the risk of administrative sanctions and product withdrawal. The review of the supply chain—from the manufacturer to the end user—is therefore a priority and immediate action.

What should companies do now?

1. Review the full text of Commission Implementing Regulation (EU) 2026/1974 to identify the conditions of use, restrictions and specific labeling requirements for the biocide ERO MN.
2. Audit the current product labeling and verify that it exactly complies with the terms of the new Union authorization. If it is not compliant, update before continuing marketing.
3. Review internal procedures for use for professional users: technical data sheets, application protocols and documentation provided to clients must reflect the harmonized conditions.
4. Communicate changes to the distribution chain: manufacturers must inform distributors and importers of the new requirements; distributors must convey the information to professional users.
5. Consult with a regulatory advisor specialized in biocides if there are doubts about the compliance of current uses with the conditions of the authorization.
6. Establish a regulatory monitoring system to detect possible modifications or additional conditions that the European Commission may introduce in the future regarding this product.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202601974